The DOI matches its Crossref record.
A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling
Abstract
Objective: The low‐affinity receptor Fcγ receptor IIb (FcγRIIb), with an immunoreceptor tyrosine‐based inhibitory motif (ITIM) in the cytoplasmic domain, down‐regulates humoral immune responses and modulates the risk of autoimmunity in animal models. The transmembrane domain of FcγRIIb may also contribute to receptor signaling. Therefore, we investigated the biologic significance of single‐nucleotide polymorphisms (SNPs) throughout the coding region. Methods: Discovery of SNPs in FCGR2B was performed by direct cycle sequencing of complementary DNA samples derived by reverse transcriptase–polymerase chain reaction. To assess the biologic significance of the nonsynonymous transmembrane SNP, we studied 3 functions influenced by the FcγRIIb transmembrane domain: tyrosine dephosphorylation of CD19, inhibition of B cell receptor (BCR)–induced calcium response, and modulation of BCR‐ or anti‐Fas–induced apoptosis. Results: The nonsynonymous C‐to‐T transition in the first cytoplasmic exon, originally reported in the Raji cell line, was not found in either the African‐American or the Caucasian population, but a nonsynonymous T‐to‐C transition at nucleotide 775 in exon 4 of FCGR2B, which changes isoleucine to threonine at residue 187 in the transmembrane domain, was significantly more common in African Americans. Using the FcγRIIb‐negative mouse B cell line IIA1.6, we expressed both allelic forms as both full‐length and truncated cytoplasmic domain constructs. The FCGR2B‐187T allele mediated a higher level of CD19 dephosphorylation (P = 0.029) and a greater degree of inhibition of the calcium response (P = 0.003) when co‐engaged with BCR than did FCGR2B‐187I, independent of the presence of the ITIM. In contrast, FcγRIIb modulation of BCR‐induced and anti‐Fas antibody–induced cell death rates were similar in IIA1.6 cells expressing either the 187I or the 187T allelic form. Conclusion: The differential activity of FCGR2B alleles suggests a novel mechanism of FcγRIIb regulation that may influence the risk of autoimmune disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications
Smith, K. G. C., & Clatworthy, M. R. (2010) · Nature Reviews Immunology · doi:10.1038/nri2762 · Cited by 543
Genetic susceptibility to systemic lupus erythematosus in the genomic era
Deng, Y., & Tsao, B. P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.176 · Cited by 379
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
Hogarth, P. M., & Pietersz, G. A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2909 · Cited by 348
Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts
Floto, R. A., Clatworthy, M. R., Heilbronn, K. R., Rosner, D. R., MacAry, P. A., Rankin, A., Lehner, P. J., Ouwehand, W. H., Allen, J. M., Watkins, N. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1288 · Cited by 316
Strait, R. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25575 · Cited by 271
Metadata
- Authors
- Li, X., Wu, J., Carter, R. H., Edberg, J. C., Su, K., Cooper, G. S., & Kimberly, R. P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 48
- Issue
- 11
- Pages
- 3242-3252
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2054178734
- Cited by
- 176
- References
- 0
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling. https://app.cochat.ai/papers/10.1002/art.11313
- The paper
- Li, X., Wu, J., Carter, R. H., Edberg, J. C., Su, K., Cooper, G. S., & Kimberly, R. P. (2003). A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis & Rheumatism. https://doi.org/10.1002/art.11313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.